EVO ICL for Refractive Surgery- Dr. Nick Bruns
Did you know #LASIK is just one type of refractive surgery? In 2024, we have numerous options, each with its own benefits. Dr. Nick Bruns talks about the #Evo ICL, an implantable contact lens introduced in 2022. So what makes the Evo ICL different? ✅ Completely invisible and provides exceptional visual outcomes ✅ Ideal for patients aged 21-45 with myopia from -3 to -20 diopters ✅ An additive procedure, perfect for high myopes without removing tissue ✅ Reduces #dryeye risk as it avoids corneal alteration ✅ Reversible and preserves corneal architecture for future premium lenses Evo ICL offers fantastic results for a wide range of myopia levels. Consider it as a versatile solution for your vision needs! 👁️💡 #EvoICL #RefractiveSurgery #SummitEyeCare #VisionCorrection #Ophthalmology Dr. Bruns Financial Disclosures: Staar Surgical References: Packer M. The EVO ICL for Moderate Myopia: Results from the US FDA Clinical Trial. Clin Ophthalmol. 2022 Dec 6;16:3981-3991. doi: 10.2147/OPTH.S393422. PMID: 36510599; PMCID: PMC9738966. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
